 Regulus Therapeutics, Inc. NASDAQ:RGLS Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Company Participants Crispina Calsada - CFO Jay Hagan - President, CEO Director Denis Drygin - Chief Scientific Officer Conference Call Participants Yanan Zhu - Wells Fargo Securities Operator Hello, and welcome to the Regulus Therapeutics Inc. Q3 2022 Earnings Conference Call. Operator Instructions. 